Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.39%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
12.79 Down 1.23(8.77%) Aug 1, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue -   6   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   6   -   -  
Operating Expenses
Research Development7,325  4,787  6,037  6,308  
Selling General and Administrative1,226  1,215  1,171  1,067  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (8,551) (5,996) (7,208) (7,375)
Income from Continuing Operations
Total Other Income/Expenses Net2  (2)1  1  
Earnings Before Interest And Taxes(8,549)(5,998)(7,207)(7,374)
Interest Expense -   -   -   -  
Income Before Tax(8,549)(5,998)(7,207)(7,374)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(8,549)(5,998)(7,207)(7,374)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (8,549) (5,998) (7,207) (7,374)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (8,549) (5,998) (7,207) (7,374)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.